“People with Parkinson’s routinely tell us they wish for some symptomatic relief - perhaps a good night sleep - not a miracle cure in 10 years from now.” Dr Wayne Markman, CEO
SYMBYX is an Australian med-tech company developing light therapies to manage previously intractable, chronic diseases and painful, inflammation-mediated conditions. One key priority is to reduce Parkinson’s disease symptoms.
Founded in December 2019 in Sydney Australia, we develop innovative medical grade, laser light devices that are non-invasive, painless to use and portable. In our Parkinson’s work, we treat primarily via the gut microbiome because through well documented research, there is a well-established linkage between gut and brain health (called the Gut-Brain-Axis). This relationship is essential to understanding many chronic disease models, especially the origin and progression of Parkinson’s.
As an innovator in developing research-backed, laser light therapies for home-use, SYMBYX's treatment protocols have been refined over 20 years of combined clinical practice and trials. We collaborate with large universities, hospitals, support and advocacy groups and leading medical professionals across Australia, Europe and North America.
CEO's Message - Dr Wayne Markman
For further updates about light therapy, SYMBYX clinical trials and new products, please subscribe via our website to our newsletter, and connect with us on social media. Please also email us anytime at email@example.com